Yan-Ge Li

发表

An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease

Yang Zhang, Fang Yang, Jian-Xing Luo, 2022, Evidence-based complementary and alternative medicine : eCAM.

AnOpen-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast GrowthFactor21 inPatientswithNonalcoholicFattyLiverDisease

Yang Zhang, Fang Yang, Jian-Xing Luo, 2022 .